Instructions
Take Another Course
Post-Test
|
|
Generic Name
|
Brand Name
|
Metformin
|
Glucophage, Glucophage XR
|
|
|
|
|
|
Metformin is an insulin
sensitizer in the biguanide
class. This class is used
for both treatment of
diabetes and pre-diabetes.
Their action is to reduce
liver production of glucose,
reducing blood glucose
levels. They also act to
improve the absorption of
glucose into body cells.
Other biguanides have been
removed from the market due
to toxic effects and it is
important to note that
diarrhea may affect up to a
third of patients taking
this medication. Lactic
acidosis is possible in
patients with kidney
problems, so is not used in
those circumstances.
|
Combinations
|
Brand Name
|
Metformin +
Glyburide
|
Glucovance,
Glibomet
|
Metformin +
Glipizide
|
Metaglip
|
Metformin +
Rosiglitazone
|
Avandamet
|
|
|
|
|
|
The chart above shows some of
the fixed dose
combination medications,
which reduce the pill
burden and make
treatments more
convenient for the
patient. Side effects
for each medication in
the combination should
be considered when
prescribing these.
|
Generic Name
|
Brand Name
|
Acarbose
|
Precose
|
Miglitol
|
Glyset
|
|
|
|
|
|
Above
are a couple of
examples of alpha-glucosidase
inhibitors, which act to
slow the digestion of
carbohydrates and thus
slow the rise of glucose
in the blood. Side
effects may include
diarrhea and flatulence
because of the increase
in carbohydrates that
remain in the intestine.
Decreased digestion of
carbohydrates can
complicate quick
treatment of
hypoglycemia, and
patients taking these
medications should be
advised to carry glucose
tablets as a source of
monosaccharides to
reverse hypoglycemia.
|
Generic Name
|
Brand Name
|
Sitagliptin
|
Januvia
|
Exenatide
Injection
|
Byetta
|
Pramlintide
Injection
|
Symlin
|
|
|
|
|
|
New classifications
and medications
should also be
mentioned. These
include DPP-4
inhibitors, such as
Sitagliptin, which
lowers glucose by
blocking an enzyme;
incretin mimetics,
such as Pramlintide
injection, which
helps the pancreas
make insulin and
slows digestion; and
anti-hyperglycemic
synthetic analogs,
such as Pramlintide
injection, which
controls
postprandial blood
glucose.
Rick Fields-Gardner
|
|